IXICO boss on 'tech bio' deal that creates solution for clinical trials - ICYMI

IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB) CEO Bram Goorden joined Proactive to discuss the company's new strategic collaboration with Medidata and its implications for growth. The partnership brings together IXICO's neuroimaging analytics with Medidata's global clinical trial platform.